# Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer

> **NCT03998566** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 6 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DEVICE:** TraceIT Tissue Spacer implantation

## Key facts

- **NCT ID:** NCT03998566
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-24
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998566, "Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03998566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*